Avanos $1.27B AIP Buyout Drives 70% Surge

Avanos Medical announced definitive agreement to be acquired by American Industrial Partners affiliates for $25 per share, valuing the company at $1.272 billion.
The $25 per share price represents a 72.1% premium to Avanos' April 13 closing price and an 82.8% premium to its 30‑day VWAP.
Shares jumped about 70% on the news, with the transaction expected to close in H2 2026 after board, shareholder and regulatory approvals.
Upon completion Avanos will be delisted from NYSE, become private, and remain headquartered in Alpharetta, Georgia; J.P. Morgan advises the deal.